• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Real-life practice: rapid improvement in itch symptomatology in patients with atopic dermatitis treated with dupilumab.

作者信息

Pistone Giuseppe, Tilotta Giovanna, Gurreri Rosario, Castelli Elena, Curiale Salvatrice, Bongiorno Maria Rita

机构信息

Section of Dermatology, Department of Health Promotion, Maternal-Infant, Internal Medicine and Specialization, University of Palermo, Italy.

出版信息

J Dermatolog Treat. 2021 Feb;32(1):127. doi: 10.1080/09546634.2019.1628914. Epub 2019 Jul 5.

DOI:10.1080/09546634.2019.1628914
PMID:31172841
Abstract
摘要

相似文献

1
Real-life practice: rapid improvement in itch symptomatology in patients with atopic dermatitis treated with dupilumab.真实临床实践：使用度普利尤单抗治疗的特应性皮炎患者瘙痒症状迅速改善。
J Dermatolog Treat. 2021 Feb;32(1):127. doi: 10.1080/09546634.2019.1628914. Epub 2019 Jul 5.
2
The evaluation of dupilumab treatment response in atopic dermatitis patients.特应性皮炎患者中度普利尤单抗治疗反应的评估。
North Clin Istanb. 2020 Nov 25;8(2):145-149. doi: 10.14744/nci.2020.42375. eCollection 2021.
3
Dupilumab treatment results in early and sustained improvements in itch in adolescents and adults with moderate to severe atopic dermatitis: Analysis of the randomized phase 3 studies SOLO 1 and SOLO 2, AD ADOL, and CHRONOS.度普利尤单抗治疗可使中度至重度特应性皮炎的青少年和成人瘙痒症状得到早期且持续的改善：随机3期研究SOLO 1、SOLO 2、AD ADOL和CHRONOS的分析。
J Am Acad Dermatol. 2020 Jun;82(6):1328-1336. doi: 10.1016/j.jaad.2020.02.060. Epub 2020 Mar 3.
4
Dupilumab improves patient-reported symptoms of atopic dermatitis, symptoms of anxiety and depression, and health-related quality of life in moderate-to-severe atopic dermatitis: analysis of pooled data from the randomized trials SOLO 1 and SOLO 2.度普利尤单抗可改善中重度特应性皮炎患者的报告症状、焦虑和抑郁症状以及健康相关生活质量：来自随机试验 SOLO 1 和 SOLO 2 的汇总数据分析。
J Dermatolog Treat. 2020 Sep;31(6):606-614. doi: 10.1080/09546634.2019.1612836. Epub 2019 Jun 9.
5
Clinical Response and Quality of Life in Patients with Severe Atopic Dermatitis Treated with Dupilumab: A Single-Center Real-Life Experience.度普利尤单抗治疗重度特应性皮炎患者的临床反应及生活质量：单中心真实世界经验
J Clin Med. 2020 Mar 13;9(3):791. doi: 10.3390/jcm9030791.
6
Weight gain in patients with severe atopic dermatitis treated with dupilumab: a cohort study.使用度普利尤单抗治疗的重度特应性皮炎患者的体重增加：一项队列研究。
BMC Dermatol. 2020 Sep 22;20(1):8. doi: 10.1186/s12895-020-00103-0.
7
Clinically Meaningful Responses to Dupilumab in Adolescents with Uncontrolled Moderate-to-Severe Atopic Dermatitis: Post-hoc Analyses from a Randomized Clinical Trial.度普利尤单抗治疗青少年中重度特应性皮炎的临床意义：一项随机临床试验的事后分析。
Am J Clin Dermatol. 2020 Feb;21(1):119-131. doi: 10.1007/s40257-019-00478-y.
8
Dupilumab treatment in adults with moderate-to-severe atopic dermatitis.度普利尤单抗治疗中重度特应性皮炎成人患者。
N Engl J Med. 2014 Jul 10;371(2):130-9. doi: 10.1056/NEJMoa1314768.
9
Real-world evidence of dupilumab efficacy and risk of adverse events: A systematic review and meta-analysis.真实世界中评估度普利尤单抗疗效和不良事件风险的证据：一项系统评价和荟萃分析。
J Am Acad Dermatol. 2021 Jan;84(1):139-147. doi: 10.1016/j.jaad.2020.08.051. Epub 2020 Aug 18.
10
Efficacy of Dupilumab on Different Phenotypes of Atopic Dermatitis: One-Year Experience of 221 Patients.度普利尤单抗治疗不同表型特应性皮炎的疗效：221例患者的一年经验
J Clin Med. 2020 Aug 19;9(9):2684. doi: 10.3390/jcm9092684.

引用本文的文献

1
Mesenchymal Stem Cells and Atopic Dermatitis: A Review.间充质干细胞与特应性皮炎：综述
Front Cell Dev Biol. 2020 May 14;8:326. doi: 10.3389/fcell.2020.00326. eCollection 2020.
2
Clinical Response and Quality of Life in Patients with Severe Atopic Dermatitis Treated with Dupilumab: A Single-Center Real-Life Experience.度普利尤单抗治疗重度特应性皮炎患者的临床反应及生活质量：单中心真实世界经验
J Clin Med. 2020 Mar 13;9(3):791. doi: 10.3390/jcm9030791.